Quick Summary:
In a rapidly advancing world of pharmaceuticals, it is crucial to stay ahead with the most updated, informed, and strategic market trends. This is where our newly released extensive research report on the global Desmopressin market comes into play.
Our detailed report on the Desmopressin market, valued at $1.2 billion in 2022 and projected to reach $2 billion by 2030, presents crucial data-driven insights, growth trends, and projections that impact key sectors such as Injectable Solution and Nasal Spray. Furthermore, it offers an in-depth analysis of the U.S and China—the two significant players in the market. Geographical trends, as well as notable markets like Japan, Canada, and Europe are also covered to give a comprehensive understanding of the market dynamics.
Moreover, the report offers updated competitors' data with a special focus on market shares and geographical presence. To facilitate user collaboration and provide additional value, we also offer interactive peer-to-peer updates, access to our digital archives and Research Platform; with complimentary updates for one year. Make the smart decision and equip your strategy with our state-of-the-art market insights today.
Global Desmopressin Market to Reach $2 Billion by 2030
The global market for Desmopressin estimated at US$1.2 Billion in the year 2022, is projected to reach a revised size of US$2 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2022-2030. Injectable Solution, one of the segments analyzed in the report, is projected to record 7% CAGR and reach US$866.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Nasal Spray segment is readjusted to a revised 5.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $332.9 Million, While China is Forecast to Grow at 10.3% CAGR
The Desmopressin market in the U.S. is estimated at US$332.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$450.7 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 5.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.Select Competitors (Total 42 Featured) -
- Amring Pharmaceuticals, Inc.
- Avenit AG
- Bachem
- BP PharmacueticalsLaboratories Company
- Ferring B.V
- Amring Pharmaceuticals, Inc.
- Northstar Rx LLC
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Desmopressin?
What is the growth rate of the Global Market for Desmopressin?
What is the forecasted size of the Global Market for Desmopressin?
Who are the key companies in the Global Market for Desmopressin?
| Report Attribute | Details |
|---|---|
| No. of Pages | 93 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 1.2 Billion |
| Forecasted Market Value ( USD | $ 2 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Amring Pharmaceuticals, Inc.
- Avenit AG
- Bachem
- BP PharmacueticalsLaboratories Company
- Ferring B.V
- Amring Pharmaceuticals, Inc.
- Northstar Rx LLC
- Pfizer, Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceuticals Industries Ltd.
